Contraceptive prevalence, any modern method in Spain
Spain: Contraceptive prevalence, any modern method was 73.5% in 2022. ▲ Rising
Contraceptive prevalence, any modern method in Spain, 1985–2022
Source: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of all women ages 15-49.
Analysis
In 2022, contraceptive prevalence, any modern method in Spain stood at 73.5%. That is the highest value across all 8 years on record.
Compared with earlier readings it is up 5.2% on the previous year and up 2.5% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Spain peaked at 73.5% in 2022 and was at its lowest, 31.9%, in 1985.
That places Spain 2nd out of 62 countries with data for 2022, putting it in the top 10%.
Contraceptive prevalence, any modern method in Spain, year by year
| Year | % of all women ages 15-49 | Change |
|---|---|---|
| 1985 | 31.9% | — |
| 1999 | 52.2% | +63.4% |
| 2009 | 63.6% | +21.9% |
| 2014 | 71.7% | +12.7% |
| 2016 | 69.9% | -2.5% |
| 2018 | 70.1% | +0.3% |
| 2020 | 69.9% | -0.3% |
| 2022 | 73.5% | +5.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 31.9% | 31.9% | 31.9% | 1 |
| 1990s | 52.2% | 52.2% | 52.2% | 1 |
| 2000s | 63.6% | 63.6% | 63.6% | 1 |
| 2010s | 70.6% | 69.9% | 71.7% | 3 |
| 2020s | 71.7% | 69.9% | 73.5% | 2 |
Countries ranked near Spain
More health data for Spain
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2629 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,290 deaths per 1,000 people (2090)
- Number of infants who die before age 1 108 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.0396 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0173 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0227 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Spain?
- Contraceptive prevalence, any modern method in Spain was 73.5% in 2022, according to Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Spain?
- The highest recorded value was 73.5% in 2022.
- What is the lowest contraceptive prevalence, any modern method recorded in Spain?
- The lowest recorded value was 31.9% in 1985.
- How does Spain rank for contraceptive prevalence, any modern method?
- Spain ranks 2nd out of 62 countries with data for 2022.
- Is contraceptive prevalence, any modern method rising or falling in Spain?
- Over the last ten years it is up 2.5%. The long-run trend across the full record is rising.
- Where does this Spain data come from?
- The figures come from Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of all women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of all women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.